Recent studies have associated three novel SNPs [PCSK7 nearGene-3 rs508487 T/C, PCSK7 intron 6 rs236911 C/A, and PCSK7 intron 9 rs236918 C/G] with an over-expression of the PCSK7 and hypertriglyceridemia [6,10,11,12,13], as well as with the risk of developing atherosclerosis and liver disease [4,10]. This evidence concerns the gene PCSK7 and liver disorder.